Lowell Therapeutics

United States
Arlington Heights, Illinois, United States

Company profile

Lowell Therapeutics company profile

Lowell Therapeutics is a pharmaceutical company that develops products for critically ill patients. It develops an anticoagulant for critically ill patients in the ICU who experience kidney failure and need to go on an artificial kidney machine called continuous renal replacement therapy (CRRT), which is 24/7 dialysis. This machine involves circulating blood outside the patient through a filter. Eventually, blood will clot in the filter unless it is anticoagulated. When the filter clogs, doctors and nurses must stop the machine to change it – throwing away clotted blood and in the process, increasing blood loss and the need for transfusions.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2018-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Total equity funding
$4M
Last funding
Seed / $4M / 2021-10-01
Last equity funding
Seed / $4M
Founders
1
Articles
4
Exited on
2021-11-15

Founders and investors

Founders

James Wilkie